Document Detail

HA1077 enhances the cytokeratin expression of mesenchymal stem cells.
MedLine Citation:
PMID:  20182378     Owner:  NLM     Status:  MEDLINE    
The objective of the study is to investigate the effect of fasudil [1-(5-isoquinolinesulfonyl) homopiperazine] (HA1077, calcium antagonist vasodilator and an inhibitor of RhoA kinase) on expression of cytokeratin (CK), DNA multiplication, and synthesis of mesenchymal stem cells (MSC). After rats were killed, MSC were separated from rats and proliferated in culture medium. The cells were randomly divided into control group, HA1077 control group, induction group, and HA1077 group. The percentage of CK19+MSC, proliferating cell nuclear antigen (PCNA), and cell cycle were determined. The test was repeated for five times. SPSS 12 software was used to analyze all the data. A P value <.05 and P < .01 were considered to be significant. The flow cytometry result showed that 1) the isolated MSC were uniformly positive for CD44, SSEA-1, CD105 but were negative for CD34, CD14, and CD45. 2) In the HA1077 control group, the percentage of CK19+MSC was similar to that in control group, which was lower than that in the induction group. In the HA1077 group, the percentage of CK19+MSC was higher than in the induction group (P < .01), in HA1077 control group (P < .01), and in control group (P < .01). 3) PCNA-positive rate in HA1077 group was highest among the groups. PCNA-positive rate of induction group was higher than that of control group and HA1077 control group. The cell cycle analysis showed that the quantity of MSC in S phase of HA1077 group was also highest. The quantity of MSC in S phase of induction group was higher than that of control group and HA1077 control group. There was no difference between the HA1077 control group and control group. HA1077 can repair burn wounds in future by promoting MSC differentiating into epidermal cell through DNA multiplication and synthesis.
Bai Xiaodong; Liu Xianhua; Liu Xiaojie
Related Documents :
24423098 - Analysis of inter-examination differences in sperm nuclear vacuoles among male patients...
7235958 - Splenectomy for immune thrombocytopenic purpura.
17448918 - The effects of campath 1h upon graft-versus-host disease, infection, relapse, and immun...
2901788 - Splenectomy for immune thrombocytopenia related to human immunodeficiency virus.
1352138 - Patterns of propulsive motility in the human colon after abdominal operations.
17413428 - Prehospital intranasal midazolam for the treatment of pediatric seizures.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of burn care & research : official publication of the American Burn Association     Volume:  31     ISSN:  1559-0488     ISO Abbreviation:  J Burn Care Res     Publication Date:    2010 Mar-Apr
Date Detail:
Created Date:  2010-03-02     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101262774     Medline TA:  J Burn Care Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  297-303     Citation Subset:  IM    
Burn and Plastic Department, The General Hospital of Chinese Armed Police Forces, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*,  pharmacology
Antigens, CD / metabolism
Cell Cycle
Flow Cytometry
Immunoenzyme Techniques
Keratins / metabolism*
Mesenchymal Stem Cells / drug effects*,  metabolism*
Proliferating Cell Nuclear Antigen / metabolism
Random Allocation
Rats, Wistar
Wound Healing / physiology
Reg. No./Substance:
0/Antigens, CD; 0/Proliferating Cell Nuclear Antigen; 103745-39-7/fasudil; 68238-35-7/Keratins; 84477-87-2/1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence and Antibiotic Resistance Pattern of Metallo-beta-Lactamase-Producing Pseudomonas aerugin...
Next Document:  High-Level Human Herpesvirus-6 Viremia Associated With Onset of Stevens-Johnson Syndrome: Report of ...